Anti-cancer chalcones: Structural and molecular target perspectives

DK Mahapatra, SK Bharti, V Asati - European journal of medicinal chemistry, 2015 - Elsevier
Abstract Chalcone or (E)-1, 3-diphenyl-2-propene-1-one scaffold remained a fascination
among researchers in the 21st century due to its simple chemistry, ease of synthesis and a …

ABCG2/BCRP: specific and nonspecific modulators

D Peña‐Solórzano, SA Stark, B König… - Medicinal research …, 2017 - Wiley Online Library
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of
structurally and functionally nonrelated anticancer drugs. This phenomenon has become a …

[HTML][HTML] Diverse molecular targets for chalcones with varied bioactivities

B Zhou, C Xing - Medicinal chemistry, 2015 - ncbi.nlm.nih.gov
Natural or synthetic chalcones with different substituents have revealed a variety of
biological activities that may benefit human health. The underlying mechanisms of action …

Flavonoids and anticancer activity: Structure–activity relationship

S Çetinkaya, KT Akça, I Süntar - Studies in Natural Products Chemistry, 2022 - Elsevier
Cancer is a multistage and heterogeneous disease caused by the accumulation of genetic
and epigenetic changes. As polyphenols exhibit antitumor properties, they are considered to …

Marine natural products as breast cancer resistance protein inhibitors

L Cherigo, D Lopez, S Martinez-Luis - Marine drugs, 2015 - mdpi.com
Breast cancer resistance protein (BCRP) is a protein belonging to the ATP-binding cassette
(ABC) transporter superfamily that has clinical relevance due to its multi-drug resistance …

Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones

E Winter, P Devantier Neuenfeldt… - Journal of medicinal …, 2014 - ACS Publications
Potent ABCG2 inhibitors were recently identified as asymmetric chromones with different
types of substituents. We here synthesized symmetric bis-chalcones that were differently …

Mechanism of inhibition of α-glucosidase activity by bavachalcone

Y Feng, H Nan, H Zhou, P Xi, B Li - Food science and technology, 2022 - SciELO Brasil
Bavachalcone is an important active component of the traditional Chinese medicine Fructus
Psoraleae. The inhibitory effect of bavachalcone on α-glucosidase activity is reported for the …

Nature and uses of fluorescent dyes for drug transporter studies

O Fardel, M Le Vee, E Jouan, C Denizot… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Drug transporters are now recognized as major players involved in
pharmacokinetics and toxicology. Methods for assessing their activity are important to …

Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position

E Winter, GJ Gozzi… - Drug Design …, 2014 - Taylor & Francis
A series of chalcones substituted by a quinoxaline unit at the B-ring were synthesized and
tested as inhibitors of breast cancer resistance protein-mediated mitoxantrone efflux. These …

Medicinal potential of heterocyclic compounds from diverse natural sources for the management of cancer

M Singh, P Sharma, PK Singh… - Mini Reviews in …, 2020 - ingentaconnect.com
Natural products form a significant portion of medicinal agents that are currently used for the
management of cancer. All these natural products have unique structures along with diverse …